Valneva Announces Closing of Approximately $102.0 Million Global Offering

NEXT STORY
Immunicum Announces Nomination Committee for the 2022 Annual General Meeting
PREV STORY
Burning Rock Schedules Third Quarter of 2021 Earnings Release on November 16, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

G1 Therapeutics to Present at Stifel 2017 Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), ...

author_avatar
NASDAQ Market News

Oncobiologics Changes Name to Outlook Therapeutics; Announces Next Steps in Executing ONS-5010 Clinical and Regulatory Strategy

Company changes name to Outlook Therapeutics, Inc.; ticker symbol to “OTLK”Jeff Evanson joins team ...

author_avatar
NASDAQ Market News

INNATE PHARMA: New preclinical data further supporting the development of IPH4301 presented at the AACR meeting

First-in-class anti-MICA/B therapeutic antibody; New data demonstrate dual mechanism of action of IPH4301, including ...

author_avatar
NASDAQ Market News